Sotera Health Company
General Information | |
Business: | We are a leading global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries. We are driven by our mission: Safeguarding Global Health®. We provide end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers in the United States and around the world. Our customers include more than 40 of the top 50 medical device companies and eight of the top 10 global pharmaceutical companies (based on revenue).
|
Industry: | Services - Health |
Employees: | 2900 |
Founded: | 1966 |
Contact Information | |
Address | 9100 South Hills Blvd, Suite 300 Broadview Heights, Ohio 44147 |
Phone Number | (440) 262-1410 |
Web Address | http://www.soterahealth.com/ |
View Prospectus: | Sotera Health Company |
Financial Information | |
Market Cap | $5962.6mil |
Revenues | $794.8 mil (last 12 months) |
Net Income | $-7.2 mil (last 12 months) |
IPO Profile | |
Symbol | SHC |
Exchange | NASDAQ |
Shares (millions): | 46.6 |
Price range | $23.00 - $23.00 |
Est. $ Volume | $1017.2 mil |
Manager / Joint Managers | J.P. Morgan/ Credit Suisse/ Goldman Sachs/ Jefferies/ Barclays/ Citigroup/ RBC Capital Markets |
CO-Managers | BNP Paribas/ KeyBanc Capital Markets/ Citizens Capital Markets/ ING |
Expected To Trade: | 11/20/2020 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |